← Back to Search

Group 1 for Glaucoma (IGDM Trial)

N/A
Waitlist Available
Led By Sarwat Salim, MD
Research Sponsored by Synabridge Corporation
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up one year
Awards & highlights

IGDM Trial Summary

To introduce a rapid and objective electrophysiological technique that can assess visual function in the magnocellular pathway, which is thought to be affected in early-stage glaucoma.

IGDM Trial Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~one year
This trial's timeline: 3 weeks for screening, Varies for treatment, and one year for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
sensitivity and specificity
Secondary outcome measures
repeatability

IGDM Trial Design

3Treatment groups
Experimental Treatment
Active Control
Group I: Group 2Experimental Treatment1 Intervention
Glaucoma suspects
Group II: Group 1Experimental Treatment1 Intervention
Glaucoma Patients
Group III: Group 3Active Control1 Intervention
Controls

Find a Location

Who is running the clinical trial?

Synabridge CorporationLead Sponsor
Yale UniversityOTHER
1,848 Previous Clinical Trials
2,737,638 Total Patients Enrolled
1 Trials studying Glaucoma
17 Patients Enrolled for Glaucoma
University of Alabama at BirminghamOTHER
1,588 Previous Clinical Trials
2,280,132 Total Patients Enrolled
6 Trials studying Glaucoma
2,409 Patients Enrolled for Glaucoma

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Recent research and studies
clinicaltrials.govStudy
Instrument for Glaucoma Early Detection and Monitoring
2008. "Instrument for Glaucoma Early Detection and Monitoring". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT00578110.
All > Glaucoma
~10 spots leftby Apr 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top